Cognition Therapeutics furnishes investor presentation with no new material facts disclosed

COGNITION THERAPEUTICS INC

Filed an investor presentation under Item 7.01 on August 28, 2024.
Presentation cover titled 'Targeting Amyloid Beta Oligomers: A Disruptive Approach to the Treatment of Alzheimer’s Disease'.
No specific financial or clinical data from the presentation are included in the filing.
Presentation is furnished, not filed, and not incorporated by reference.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.